The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2008-2012
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 16,473 98.1% 12,363 98.3% 2,317 97.6% 1,447 98.2% 122 97.6% 3,634 98.2%
Epidermoid carcinomad (8050-8131) 11,051 65.8% 8,034 63.9% 1,818 76.6% 965 65.5% 75 60.0% 2,483 67.1%
Squamous cell carcinoma (8070) 7,658 45.6% 5,509 43.8% 1,317 55.5% 665 45.1% 57 45.6% 1,563 42.3%
Squamous cell, keratinizing (8071) 1,152 6.9% 833 6.6% 197 8.3% 101 6.9% - - 305 8.2%
Squamous cell, non-keratinizing (8072) 1,493 8.9% 1,132 9.0% 202 8.5% 136 9.2% - - 427 11.5%
Squamous cell, Microinvasive (8076) 499 3.0% 376 3.0% 61 2.6% 42 2.9% - - 131 3.5%
Other (8050-8069, 8073-8075,8077-8131) 249 1.5% 184 1.5% 41 1.7% 21 1.4% - - 57 1.5%
Adenocarcinomae 4,699 28.0% 3,800 30.2% 380 16.0% 429 29.1% 37 29.6% 987 26.7%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 2,511 15.0% 2,042 16.2% 198 8.3% 220 14.9% 17 13.6% 538 14.5%
565 3.4% 439 3.5% 59 2.5% 60 4.1% - - 128 3.5%
Other adenocarcinomasf 1,623 9.7% 1,319 10.5% 123 5.2% 149 10.1% - - 321 8.7%
Other specific carcinomasg 264 1.6% 209 1.7% 33 1.4% 19 1.3% - - 57 1.5%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 459 2.7% 320 2.5% 86 3.6% 34 2.3% - - 107 2.9%
Sarcomah 61 0.4% 42 0.3% - - - - - - - -
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 162 1.0% 107 0.9% 30 1.3% 17 1.2% - - 32 0.9%
Unspecified (8000-8005) 89 0.5% 65 0.5% - - - - - - 20 0.5%
Total 16,785 100.0% 12,577 100.0% 2,373 100.0% 1,473 100.0% 125 100.0% 3,699 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.